Magyar Nephrologiai Társaság 44th Course on Advances in Nephrology, Dialysis, and Transplantation
Rendezvény kezdete: 2012.12.06.Rendezvény vége: 2012.12.09. Helyszín: Olaszország, Milánó, Milan Marriott Hotel Lessons are given by the best international experts and the Course is attended by more than one thousand participants (nephrologists, cardiologists and internists).
More than 20 companies of the pharmaceutical, laboratory, instrumentation, and scientific publishing field are involved each year as sponsors and several of them organize satellite meetings during the intervals between lessons or on the starting day of the Course.
A simultaneous translation (Italian-English and vice-versa) is operative during the whole course, allowing the active attendance not only of Italian, but also of foreign participants.
This year we are organizing the 44th Edition of the Course that will be held at the Milan Marriott Hotel (www.marriott.com/hotels/travel/milit-milan-marriott-hotel/, via Washington 66), on December 6-9, 2012.
Kapcsolódó dokumentumok (2)
Magyar Dermatológiai Társulat 1st European School of Dermato-Oncology (EADO)
Rendezvény kezdete: 2013.01.17.Rendezvény vége: 2013.01.19. Szakterület(ek): Bőrgyógyászat
Helyszín: Germany, 10117 Berlin, NH Berlin Friedrichstrasse, NH Berlin Friedrichstrasse A rendezvény Web oldala: http://www.dermato-oncology2013.com/ The EADO initiates a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of loco-regional disease and distant metastatic disease. It is intended to organize this course every year in different countries.
Target Audience
This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course.
The maximum number of delegates is 100. In order to make the course available throughout Europe, places will be made available on a first come first served basis to all applicants.
Magyar Tüdőgyógyász Társaság 5th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
Rendezvény kezdete: 2013.02.08.Rendezvény vége: 2013.02.09. Szakterület(ek): Tüdőgyógyászat
Tudományos információ: Antonella Caminati Munkahely neve: Division of Pulmonary Diseases Címe: Ospedale San Giuseppe, MultiMedica - Milan, Italy Szervező: Victory Project Congressi Címe: Via C. Poma, 2 - 20129 Milan, Italy Tel: +39 02 89 05 35 24 Fax: +39 02 20 13 95 E-mail: info@victoryproject.it Helyszín: Milan, 20123 Italy, Corso Magenta 61, Palazzo Delle Stelline The 5th International Meeting on Pulmonary Rare Diseases and Orphan Drugs will take place in Milan, Italy, on February 8–9, 2013.
Main Topics:
Pulmonary Vascular Diseases
Vasculitis
Eosinophilic Lung Diseases
Connective Tissue Disorders and the Lung
IPF and other Interstitial Lung Diseases
Drugs and the Lung
The submission deadline for abstracts is December 15th, 2012.
Please send the abstracts to info@victoryproject.it
You can find further information in the attached documents - "Kapcsolódó dokumentumok"
Magyar Immunológiai Társaság Cross-Border Healthcare in Europe:
Rendezvény kezdete: 2013.02.26.Rendezvény vége: 2013.02.26. Helyszín: Belgium, Brussels, The Silken Berlaymont Hotel A rendezvény Web oldala: http://publicpolicyexchange.co.uk/events/DB26-PPE2.php Cross-Border Healthcare in Europe:
Removing the Barriers to Deliver Clarity and Quality
The EU Directive on Patients’ Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border healthcare and reimbursement of these costs are not always clear and, as such, the Directive provides more transparency and also clarifies who is responsible for quality and safety of care in cross-border settings.
This timely international symposium will tackle challenges to the implementation of cross-border healthcare and its impact on patient safety and quality, health professionals’ mobility and European standards for healthcare services.